SEC Form 3/A · accession 0001209191-16-155463
Lineage Cell Therapeutics, Inc. · LCTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 3/A). It replaces an earlier filing for the same period.
Reporting owner
James A. Knight
Officer — Sr VP, Head of Corporate Dev
Period of report
Oct 19, 2016
Accepted (ET)
Dec 15, 2016 · 5:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000876343
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, no par value | holding | — | — | — | 17,704 | D |
Table II — derivative securities
No Table II lines on this filing.